Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NVAF)

Next Previous
Search
Trial Profile

Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation (NVAF)

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Mar 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edoxaban (Primary)
  • Indications Cardiovascular disorders; Embolism; Stroke
  • Focus Adverse reactions
  • Acronyms ETNA-AF-KOR-TWN
  • Sponsors Daiichi Sankyo Inc

    • Most Recent Events

    • 26 Oct 2022 Results of sub analysis of the Global EMIT-AF/VTE program(NCT02950168, NCT02951039) comparing the baseline characteristics, periprocedural management, and outcomes of patients who underwent major or nonmajor surgery.presented at the ANESTHESIOLOGY 2022 Annual Meeting of the American Society of Anesthesiologists
    • 11 Oct 2022 Results of a sub-group analysis from two clinical studies (NCT02950168 and NCT02951039) assessing physician-guided periprocedural management of Edoxaban therapy and clinical outcomes in patients undergoing endoscopic procedures presented at the 30th United European Gastroenterology Week
    • 29 Aug 2022 Results presented at the ESC Congress 2022 - Annual Congress of the European Society of Cardiology

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top